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SUMMARY 
Predisposition to diabetes is possibly associated with gene polymorphisms of the renin–angiotensin system 
(RAS). Angiotensin-converting enzyme (ACE) gene is one of the genes of the RAS system whose 
polymorphisms have been suggested to be risk factors for type 2 diabetes melitus (T2DM). The involvement 
of the ACE gene polymorphism in diabetes show inconsistent results across ethnic groups as revealed by 
earlier studies. In the present case–control study, we investigated the association of insertion/deletion (I/D) 
polymorphism of the 287 bp DNA fragment in intron 16 of ACE gene with genetic predisposition to diabetes 
in the Bantu ethnic group of South West Cameroon. The polymorphism was determined in diabetic subjects 
(n= 50) and non-diabetic subjects (n=50) and the distribution of three genotypes (II, ID, and DD) was 
significantly different between the diabetic and non-diabetic groups  (χ2 = 10.3, p = 0.001).  Also, frequency 
of D allele was higher in the diabetic patients than in the non-diabetic subjects (p= 0.03). Our data suggest 
that the D allele of ACE gene polymorphism is associated with the genetic predisposition to develop T2DM.  
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Introduction 
The prevalence of T2DM in Cameroon ranges from 
1.0% in rural areas to 6.1% in urban areas [1]. The 
susceptibility of T2DM is strongly hereditary with 
concordance in twins and family aggregations. The 
risk of an offspring having diabetes doubles if the 
individual has a history of diabetes and furthermore, 
the individual has 80% chances of acquiring diabetes 
[2]. Moreover, the fact that susceptibility varies with 
ethnic group further strengthens the involvement of a 
genetic factor in predisposition to diabetes [3, 4]. 
Many studies have showed that the genetic 
polymorphisms of some genes of the RAS system are 
associated with T2DM [5] and the ACE gene 
polymorphism is one of them. There is evidence that 
angiotensin converting enzyme (ACE) is associated 
with T2DM: The renin-angiotensin system (RAS) 
leads to the production of angiotensin II, a 
vasoconstrictor, that affects glucose homeostasis and 
involved in the pathogenesis of DM through 
inhibition of insulin signal transduction, reduction of 
glucose intake, resistance to insulin and destruction 
of the beta cells of the pancreas by oxidative stress 
[6]. Further more, ACE inhibitors improve glucose 
utilization and suppresses hepatic glucose production 
in type 2 diabetes [7] and there is a correlation 
between serum ACE activity and ACE polymorphism 
[8].  
 This ACE gene consists of a 26 exons and spans 21 
kp on chromosome 7. There is a 287 bp DNA 
fragment insertion (insertion, I)/deletion (deletion, D) 
polymorphism in intron 16 of ACE gene [9]. 
The relationship between I/D polymorphism of the 
ACE gene and T2DM has been inconsistent among 
different ethnic groups.  For example, studies 
reported a strong association of ACE gene 
polymorphisms with T2DM in Northern India [10]; 
Bhavani established positive association of ACE 
polymorphism with T2DM in south India [11]. The 
ACE I/D polymorphism is significantly associated 
with T2DM in Arab ethnicity [12, 13], Malaysian 
subject [14], Indonesia [15], Bahrain [13]. In other 
reports, the D allele is associated with T2DM in 
Egyptian patients [9] and Asian population [16]. 
Contrary to these reports, Prasad and Ajay Kumar 
reported no relation between ACE gene and T2DM 
among North Indian population [17] and Chinese 
populations  [18, 19], Lebanese [20] and the Tunisian 
population [21]. It is therefore evident that the 
predisposition of T2DM patients to ACE 
polymorphism is dependent on the ethnic group.  
Such studies have never been carried out in 
Cameroon. Cameroon is made of ten Regions divided 
into three ethnic groups: the Bantu (Centre, South and 
Littoral Regions), Semi-Bantu (Northwest, 
Southwest and West Regions) and Fulbe (Adamawa, 
North, Far North and East) [22] with rare 
intermarriages between ethnic groups either due to 
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traditional, cultural or religious beliefs and dialect 
barriers. Hence, the principal objective of this work 
is to investigate the possible relationship that exists 
between ACE gene polymorphism and risk of 
developing essential diabetes in the Semi-Bantu 
ethnic group in Buea, South West Region of 
Cameroon. 
Materials and Methods 
Study population 
The study group comprised of 50 diabetic controls 
and 50 diabetic subjects of between 31 and 73 years 
inclusive. All diabetic subjects were resident in Buea, 
belonging to the semi Bantu ethnic group without any 
known ancestors of other ethnic origin and recruited 
from the diabetic and hypertension clinic at the 
Regional hospital Buea, South West Region. Diabetic 
subjects were those with a fasting blood sugar (FBS) 
of above 110 (mg/dl) or who were already placed on 
diabetic medication. These patients were required to 
be free of secondary hypertension [systolic blood 
pressure (SBP) of at most 140mmHg and a diastolic 
blood pressure (DBP) of at most 90 mmHg] and must 
have been diagnosed with diabetes before the age of 
70 years. These subjects must have had a family 
history of diabetes in their parents and/or siblings. 
Non-diabetic controls were recruited randomly from 
the Buea Municipality and with a fasting blood sugar 
(FBS) of 90-110 (mg/dl). These individuals had never 
been treated with anti diabetic medications, had no 
family history of diabetes. All of the subjects were 
unrelated and were native Cameroonians of the Semi 
Bantu ethnic group of the South West Region. All 
subjects gave their consent and ethical clearance for 
this work was obtained from the Faculty of Health 
Science ethical committee of the University of Buea. 
Administrative authorization was obtained from the 
South West Region Delegation of Health.  
Collection of anthropometric and biochemical 
data. 
 A structured questionnaire was used for data 
collection on anthropometric variables (height, 
weight, and sex), duration of diabetes, family history 
and complications of hypertension. Body mass index 
(BMI) was calculated as weight, divided by height 
squared (kg/m2). Resting blood pressure was 
measured in the right upper arm of subjects using a 
cardiocheck PA analyser. FBS was measured using 
the OneTouch UltraSoft lipid profile strip and 
analyzer. Serum lipid levels were measured using 
lipid profile test strips that provided a quantitative 
measurement of total cholesterol (TC), high density 
lipoprotein cholesterol (HDL-C), triglycerides (TG) 
and low density lipoprotein cholesterol (LDL-C) in 
blood. Table 1 shows the mean clinical and 
anthropometric profile of normal and diabetic 
subjects 
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DNA extraction 
Whole blood from participants was collected by 
venepuncture in EDTA-free microtainer tubes by a 
trained nurse as described by [23]. DNA was 
extracted from blood using the GenElute Blood 
Genomic DNA kit (Sigma) as described by the 
manufacturer.   
Genotyping 
Genotyping was carried out with genomic DNA 
isolated from human leukocytes by a commercial 
Genomic DNA extraction kit for Blood (Sigma). 
Angiotensin converting enzyme (ACE) 
insertion/deletion (I/D) variant  [24] was assayed by 
PCR amplification of the target in a 25 μL reaction 
mixture comprised of 0.5 μg genomic DNA, 25 µM 
each primer, 10µl of deionized water and 12.5 μL of 
PCR master mix containing 2.5 mM each of dNTP 
(dATP, dCTP, dGTP and dTTP), 2.0 mM MgCl2, 1X 
Taq buffer and 0.05 U/µL Taq DNA polymerase. 
Primer sequences used for the amplification of the 
ACE gene were: 5'-
CTGGAGACCACTCCCATCCTTTCT-3' 
(Forward) and 5'-GATGTGGCCATCACATT 
CGTCAGAT-3' (Reverse). The predenaturation step 
was carried out for 3 min at 94oC. This was followed 
by a denaturation step at 94oC for 45 sec, annealing 
at 58oC for 45 sec, and polymerization at 72oC for 45 
sec with a final extension at 72oC for 7 min. Forty 
PCR amplification cycles were carried out in Applied 
Biosystems thermal cycler. PCR products were 
visualized on 2% agarose gels containing ethidium 
bromide.  
Statistical analyses 
All the statistical analyses were carried out using 
SPSS (Chicago, IL) software version 14.0 for 
Microsoft Windows. Continuous variables were 
compared between the groups using two-tailed 
student's t-test. Allelic frequencies were calculated 
by gene-counting method and the genotype 
distribution with Hardy-Weinberg expectations by a 
chi-squared test. The statistical significance of the 
traits and values between genotypes (D/D vs I/D or 
I/D vs I/I) were compared using one-way ANOVA. 
A level of p < 0.05 was considered statistically 
significant. 
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Results 
The clinical and demographic characteristics of the studied groups are demonstrated in Table 1.  
Table 1: Mean clinical and anthropometric profile of normal and diabetic subjects 
Parameter Normal subjects Diabetic subjects p values 
Age (years) 52 ± 8.7 54.6 ± 10.6 0.212 
DM Duration (years) 0.0 7.4 ± 2.1 NA 
Sex ratio (male: female) 19:31 17:33 NA 
BMI (Kg/m2). RV: 18.5-24.99 29.63 ± 6.91 47.06 ± 10.19 0.0001* 
SBP (mm Hg). RV:  140 132 ± 20 142 ± 24 0.054 
DBP (mm Hg). RV:  90 85 ± 11 90 ± 20 0.129 
FBS(mg/dl). RV: 70-110 67 ± 12 148 ± 47 0.0001* 
HDL-C (mg/dl). RV: 30-85 59±35 70 ± 24  0.098 
LDL-C (mg/dl) RV:  140 75 ± 37  111 ± 55 0.001* 
TG (mg/dl). RV:  160 91 ± 45 117 ± 45 0.004* 
TC (mg/dl). RV  200 169 ± 44 175 ± 42 0.486 
Mean age, diabetes duration, body mass index (BMI), 
blood glucose level, Systolic blood pressure (SBP) 
and diastolic blood pressure (DBP), fasting blood 
sugar (FBS) level, high density lipoprotein (HDL-C), 
low density lipoprotein (LDL-C), Triglyceride (TG), 
total cholesterol (TC) levels, are summarized as mean 
± SD (standard deviation); RV: Reference value; NA: 
Non applicable. 
No statistically significant differences were detected 
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between the studied groups regarding age, sex and 
body mass index, TC, HDL-C, SBP and DBP. 
However, there was a statistically significant 
difference as regards FBG, disease duration, BMI, 
LDL-C and TG (p<0.05).  
Genotype distribution and allele frequency 
Three genotypes were recognized: II with one band 
at 490 bp, DD with one band at 190 bp and ID a 
heterozygote type with 2 bands at 490 and 190 bp 
(Figure 1).
  
Figure 1: Detection of ACE I/D polymorphism on DNA samples after PCR analysis. Lane M: DNA marker 
(Lambda Hind III); Lanes 1: Negative control; Lanes 2,4, 5: I/D heterozygous (490bp and190bp); Lane 3: D/D 
homozygous (190bp), Lanes 6: I/I homozygous (490bp). Arrows indicate the different allele forms.  
Data for the distribution of ACE insertion/deletion 
(ACE I/D) genotypes and alleles in the studied groups 
is illustrated in Table 2. The frequency of the DD 
genotype of ACE gene was significantly higher 
(p<0.05) in diabetic patients than the controls (58% 
and 30%respectively) while it was inversely true for 
the ID genotype (38% and 68% respectively p>0.05).  
Table 2: ACE genotype and allele frequencies in control and diabetic group 
Group n  Genotypes (%) Allele  
II ID DD I D 
Control 50 1 (2) 34 (68) 15 (30) 36 64 
Diabetic 50 2 (4) 19 (38) 29 (58) 23 77 
      p =  0.001                  χ2= 10.3    p = 0.003                      
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No significant differences were observed in the II 
genotype in diabetic patients and controls (2 vs. 4%). 
The frequency of ACE D allele was insignificantly 
higher (p>0.05) in the diabetic patients (77%) than 
controls (64%).  
Also, I allele frequency was insignificantly lower 
(p>0.05) in the diabetic patients (23%) than controls 
(36%). 
ACE genotype distributions in three groups were in 
line with Hardy-Weinberg equilibrium (all P > 0.05, 
data not shown). 
Comparing the studied parameters in diabetic patients 
with the risky genotypes DD and DI to those with the 
II genotype revealed that these risky genotypes were 
insignificantly associated with serum lipid levels, 
BMI and blood pressure but significantly associated 
with higher FBS, (p <0.05), these data are 
summarized in Table 3. 
Table 3: Variation of Anthropometric and biochemical variables with ACE genotype     
Genotype LDL-
C 
(mg/dl
) RV: 
 140 
HDL-
C 
(mg/dl
) RV: 
30-85 
TG 
(mg/dl) 
RV:  
160 
TC 
(mg/dl) 
RV  
200 
Glucose 
(mg/dl) 
RV: 70-
110 
BMI 
(Kg/m2
) RV: 
18.5-
24.99 
SBP 
(mm 
Hg) 
RV:  
140 
DBP 
(mm 
Hg) 
RV:  
90 
II (53) 80±32 
 
60±28 92±46 164±41 71±8 29±6 129±11 87±05 
ID (44) 107±4
6 
68 ± 
30 
103±44  170±43 137±29* 30±30 140±09 89±08 
DD (3) 110±1
4 
69±15 115±23 176±21 147±21* 32±17 143±05 91±04 
Note: Compared to II genotype: *P < 0.05 
 
Discussion 
Although there is evidence for a significant 
association between the I/D polymorphism of the 
ACE gene and the risk of T2DM, the contribution of 
ACE gene variants to diabetic development still 
remains controversial.  Analysis for the association of 
the ACE I/D polymorphism with T2DM has been 
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published in different ethnic groups [3, 10, 11, 13, 14, 
15]. However, some researchers reported no obvious 
association between a specific ACE genotype and 
diabetes in other ethnic groups [17, 18, 19, 21]. These 
reports suggest that the involvement of ACE I/D 
polymorphism in the T2DM varies among different 
ethnic/racial groups [25].   
In this present study, we found an association 
between the ACE I/D polymorphism and T2DM. The 
frequencies of both ID and DD ACE genotypes as 
well as the minor D allele frequency were 
significantly higher in the T2DM patients as 
compared to controls of the studied population. These 
results indicate that ACE gene deletion 
polymorphism is associated with the diabetes in the 
Semi Bantu ethnic group of the SWR of Cameroon. 
These results are consistent with other reports where 
the DD genotype and the D allele are associated with 
T2DM in Egyptian patients [9], Indian [26], Iranian  
[27] and Tunisian [28] populations. However the 
reason why ACE gene polymorphism is associated to 
Cameroonian patients of this ethnic group with type 
2 diabetes is unknown and therefore will require 
further investigations.  
In addition, this study also found that in the different 
genotypes, TG and LDL-C and TC, levels, SBP and 
DBP in D allele carriers were higher than that of I 
allele carriers although the differences were not 
statistically significant. These results indicate that our 
patients may not have developed the metabolic 
syndrome but run the risk of developing it. The 
mechanism by which ACE gene polymorphism 
affects the lipid levels is unclear and is worth further 
exploring. On the other hand, levels of FBG were 
significantly higher in D allele carriers than those of 
I thereby suggesting that the ACE gene I/D 
polymorphism is a risk factor for T2DM in the Bantu 
ethnic group of the SWR of Cameroon and the D 
allele may predispose subjects to T2DM.  
Identifying the risk factors of T2DM and genotyping 
these SNPs among semi-Bantus ethnic group in Buea 
can help identify at risk individuals in the Bantu 
ethnic group, hence create awareness by providing 
better understanding of the disease complications, 
management, early prevention and thus a change in 
lifestyle of these patients. Furthermore these results 
may initiate the formulation of governmental policies 
to prevent and control this disease in this population. 
Conclusion 
The ACE gene I/D polymorphism is a risk factor for 
T2DM in the Semi Bantu ethnic group of the SWR of 
Cameroon and the D allele predisposes these subjects 
to T2DM.  
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